Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories Covid-19 Tests

Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test. While Vivera did work with LuSys Laboratories in mid-2020, the scope of that engagement was limited to development of a United States […]